CNS neuroscience & therapeutics · 2025
Association Between Blood Urea Nitrogen and Delirium in Critically Ill Elderly Patients Without Kidney Diseases: A Retrospective Study and Mendelian Randomization Analysis.
СтатьяПоддержка правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fang Yipeng, Tang Xiaohong, Gao Ying, Xie Hui, Shen Yuehao, Peng Min, Liu Jie, Zhang Yunfei, Cui Yan, Xie Keliang
Аннотация
OBJECTIVE: This study investigates the association between blood urea nitrogen (BUN) levels and the risk of delirium in critically ill elderly patients without kidney disease.
METHODS: A retrospective analysis was conducted using data from the MIMIC-IV database. The relationship between BUN and delirium risk was illustrated through the restricted cubic spline (RCS) method. Patients were stratified by BUN levels and examined for delirium incidence using logistic regression, subgroup analysis, and sensitivity analysis. Mendelian randomization (MR) was employed to explore potential causal relationships.
RESULTS: The maximum BUN level exhibited the strongest non-linear positive association with the odds of delirium. Compared to the Q1 group, both the Q3 (23-31 mg/dL) and Q4 (> 31 mg/dL) groups consistently showed increased odds of developing delirium. Subgroup analysis identified a significant interaction between BUN and midazolam, with the association only evident in patients not exposed to midazolam. After adjusting for baseline characteristics, the odds ratio for delirium was found to range from 1.35 to 1.39 in those with BUN levels exceeding 23 mg/dL. However, the MR analysis did not reveal any significant causal relationship (all p > 0.05).
CONCLUSION: In conclusion, elevated BUN may be a risk factor for delirium in critically ill elderly patients without renal dysfunction, with this potential link possibly modulated by midazolam exposure.
METHODS: A retrospective analysis was conducted using data from the MIMIC-IV database. The relationship between BUN and delirium risk was illustrated through the restricted cubic spline (RCS) method. Patients were stratified by BUN levels and examined for delirium incidence using logistic regression, subgroup analysis, and sensitivity analysis. Mendelian randomization (MR) was employed to explore potential causal relationships.
RESULTS: The maximum BUN level exhibited the strongest non-linear positive association with the odds of delirium. Compared to the Q1 group, both the Q3 (23-31 mg/dL) and Q4 (> 31 mg/dL) groups consistently showed increased odds of developing delirium. Subgroup analysis identified a significant interaction between BUN and midazolam, with the association only evident in patients not exposed to midazolam. After adjusting for baseline characteristics, the odds ratio for delirium was found to range from 1.35 to 1.39 in those with BUN levels exceeding 23 mg/dL. However, the MR analysis did not reveal any significant causal relationship (all p > 0.05).
CONCLUSION: In conclusion, elevated BUN may be a risk factor for delirium in critically ill elderly patients without renal dysfunction, with this potential link possibly modulated by midazolam exposure.